Read More Pharma Industry News Why platinum-resistant ovarian cancer remains a high-stakes proving ground for CDH6-targeted ADCs Can SIM0505 change NextCure’s oncology outlook? Read why platinum-resistant ovarian cancer is the key test case for 2026. bySoujanya RaviApril 10, 2026